Stereotaxis Announces Second Quarter Earnings Release Date and Conference Call Read more about Stereotaxis Announces Second Quarter Earnings Release Date and Conference Call
Stereotaxis to Present at the C.E. Unterberg, Towbin Emerging Growth Conference Read more about Stereotaxis to Present at the C.E. Unterberg, Towbin Emerging Growth Conference
Stereotaxis Announces 1000 Worldwide Atrial Fibrillation Procedures with Niobe(R) System Read more about Stereotaxis Announces 1000 Worldwide Atrial Fibrillation Procedures with Niobe(R) System
Stereotaxis Announces 1000 Worldwide Atrial Fibrillation Procedures with Niobe System Read more about Stereotaxis Announces 1000 Worldwide Atrial Fibrillation Procedures with Niobe System
Stereotaxis to Present at Goldman Sachs 28th Annual Global Healthcare Conference Read more about Stereotaxis to Present at Goldman Sachs 28th Annual Global Healthcare Conference
Stereotaxis to Present at Leerink Swann & Company Rhythm Revival: Atrial Fibrillation Roundtable Conference Read more about Stereotaxis to Present at Leerink Swann & Company Rhythm Revival: Atrial Fibrillation Roundtable Conference
Stereotaxis Announces Record First Quarter Results Read more about Stereotaxis Announces Record First Quarter Results
Biosense Webster and Stereotaxis Expand Strategic Alliance and Extend Current Agreement Read more about Biosense Webster and Stereotaxis Expand Strategic Alliance and Extend Current Agreement
Stereotaxis' Technology to be Prominently Featured at Heart Rhythm 2007 Scientific Sessions Read more about Stereotaxis' Technology to be Prominently Featured at Heart Rhythm 2007 Scientific Sessions
Stereotaxis Introduces Odyssey(TM), the First Ever Fully Integrated and Networked Single Screen Solution for the Interventional Electrophysiology Lab Read more about Stereotaxis Introduces Odyssey(TM), the First Ever Fully Integrated and Networked Single Screen Solution for the Interventional Electrophysiology Lab